Regulated Medicines and Substances Portal

.navbar-toggler:focus { box-shadow: 0 0 0 0 !important; } .navbar-toggler .fa-bars { font-size: 1.5em !important; color: #636363 !important; } @media (min-width: 320px) and (max-width: 480px) { .gov-logo { margin-top: 20px !important; } } .content-card__col--media .wp-block-video { height: 450px !important; } .content-card__col--media-h450 figure { height: 450px !important; } .content-card__col--media-h600 figure { height: 600px !important; } .navbar-nav > li { list-style-type: none; } ul li { list-style-type: disc; } /* ============================

Recall Of Blood Pressure Drug

M E D I A   R E L E A S E

December 24, 2025

Ministry of Health Advises on Recall of Blood Pressure Drug

Port of Spain, December 24, 2025: The Ministry of Health (MoH), via its Chemistry, Food and Drug Division (CFDD), advises the public of a voluntary recall affecting specific lots of Bisoprolol Fumarate and Hydrochlorothiazide Tablets, a generic medication used to treat hypertension.

Share

Tags